Resistin and interleukin-6 exhibit racially-disparate expression in breast cancer patients, display molecular association and promote growth and aggressiveness of tumor cells through STAT3 activation.
about
Obesity-Related Digestive Diseases and Their Pathophysiologyp-21 activated kinase 4 (PAK4) maintains stem cell-like phenotypes in pancreatic cancer cells through activation of STAT3 signalingSuggestive evidence of a multi-cytokine resistin pathway in humans and its role on cardiovascular events in high-risk individualsMicroRNA-345 induces apoptosis in pancreatic cancer cells through potentiation of caspase-dependent and -independent pathways.Size is an essential parameter in governing the UVB-protective efficacy of silver nanoparticles in human keratinocytesDevelopment and Characterization of a Novel in vitro Progression Model for UVB-Induced Skin CarcinogenesisElevated Resistin Gene Expression in African American Estrogen and Progesterone Receptor Negative Breast CancerRationally Repurposing Ruxolitinib (Jakafi (®)) as a Solid Tumor TherapeuticRuxolitinib synergizes with DMF to kill via BIM+BAD-induced mitochondrial dysfunction and via reduced SOD2/TRX expression and ROSDocosahexaenoic acid inhibits 12-O-tetradecanoylphorbol-13- acetate-induced fascin-1-dependent breast cancer cell migration by suppressing the PKCδ- and Wnt-1/β-catenin-mediated pathwaysRacial disparities in prostate cancer: a molecular perspective.Biological basis of cancer health disparities: resources and challenges for research.Resistin confers resistance to doxorubicin-induced apoptosis in human breast cancer cells through autophagy induction.Potential therapeutic applications of plant toxin-ricin in cancer: challenges and advances.Targeting polyamine biosynthetic pathway through RNAi causes the abrogation of MCF 7 breast cancer cell line.Resistin potentiates chemoresistance and stemness of breast cancer cells: Implications for racially disparate therapeutic outcomes.Epigenetic basis of cancer health disparities: Looking beyond genetic differences.Emerging evidence for the role of differential tumor microenvironment in breast cancer racial disparity: a closer look at the surroundings.The fat and the bad: Mature adipocytes, key actors in tumor progression and resistance.MYB is a novel regulator of pancreatic tumour growth and metastasis.Activation of porcine alveolar macrophages by Actinobacillus pleuropneumoniae lipopolysaccharide via the TLR4/NF-κB mediated pathway.ETV4 Facilitates Cell-Cycle Progression in Pancreatic Cells through Transcriptional Regulation of Cyclin D1.Racial disparity in breast cancer: can it be mattered for prognosis and therapy.Diabetes-associated dysregulated cytokines and cancer.Role of family microRNA in breast cancerGemcitabine treatment promotes immunosuppressive microenvironment in pancreatic tumors by supporting the infiltration, growth, and polarization of macrophages
P2860
Q28073381-09DA7BA0-D304-4265-9F50-083CE45C9C0FQ28269527-9F88CDC3-2014-4D33-B396-2E95FEE9F51EQ30841816-2BE1987E-41A8-4CD7-8727-AE8F3067BDC4Q35738711-49019FAB-A5AC-46A5-8292-38BBE5755D72Q35776514-30B40560-8B09-4642-A81F-1E851F126A68Q36039774-5FE9BBAC-F3E9-4930-B623-0F4A64FF3BFEQ36055386-FD946A1B-608C-49FE-9BB7-782777B841E1Q36995729-7D38962F-7560-46AA-A728-25C414E33DBEQ37109457-E589FC81-61AA-40D8-BF81-925AE5495F86Q37295281-F78FE915-5628-4E70-89D5-1702FC323558Q37592047-ECBBFE43-A1FA-40DB-BB05-D1E9DB48F41CQ37596808-51B3CACB-408A-422C-B533-13492D9AEC76Q37743518-A90D38C1-9F5F-447C-BA32-904F73E97405Q38582930-FF797515-3152-4DC6-BED9-5FC6122AABDDQ38843396-2FF001F3-4398-486F-836E-E4B3865C5E27Q38902610-02A6529A-7613-4575-972F-1CD5758EFC0DQ39096966-D6F4D837-412E-4284-9794-B6613BF14E7CQ39254902-F57BEA5A-CE11-4DEE-84CC-12011511392AQ39356609-826B0498-9071-408E-840A-EA71C37574C6Q41842858-A4E7E784-9638-4728-A79A-251EE9B33A05Q47327523-276CE0A0-03CF-49D6-B365-DA84282A7D0EQ47424104-2C2AAC8D-FCD6-4685-B48B-4AC5C5B3824EQ47692378-AA7DE014-1E98-4EAC-AEB7-B68FF8A23E61Q55331908-8D78D942-0FBA-496B-B67E-19B6555A8B21Q57119043-C9C7945C-9FEF-40CC-AC08-416036AF8E52Q58790835-5E326E98-3FF6-4ACD-AA71-D7E98FBF2055
P2860
Resistin and interleukin-6 exhibit racially-disparate expression in breast cancer patients, display molecular association and promote growth and aggressiveness of tumor cells through STAT3 activation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Resistin and interleukin-6 exh ...... ells through STAT3 activation.
@ast
Resistin and interleukin-6 exh ...... ells through STAT3 activation.
@en
type
label
Resistin and interleukin-6 exh ...... ells through STAT3 activation.
@ast
Resistin and interleukin-6 exh ...... ells through STAT3 activation.
@en
prefLabel
Resistin and interleukin-6 exh ...... ells through STAT3 activation.
@ast
Resistin and interleukin-6 exh ...... ells through STAT3 activation.
@en
P2093
P2860
P356
P1433
P1476
Resistin and interleukin-6 exh ...... ells through STAT3 activation.
@en
P2093
Ajay P Singh
Arun Bhardwaj
Donna L Dyess
James E Carter
Nikhil Tyagi
Sachin K Deshmukh
Sanjeev K Srivastava
Saravanakumar Marimuthu
Seema Singh
Valeria Dal Zotto
P2860
P304
11231-11241
P356
10.18632/ONCOTARGET.3591
P407
P577
2015-05-01T00:00:00Z